Mockenhaupt M - Search Results

1

Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.

Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group. Kardaun SH, et al. Among authors: mockenhaupt m. Br J Dermatol. 2013 Nov;169(5):1071-80. doi: 10.1111/bjd.12501. Br J Dermatol. 2013. PMID: 23855313

2

Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis.

Paulmann M, Reinkemeier F, Lehnhardt M, Mockenhaupt M. Paulmann M, et al. Among authors: mockenhaupt m. Front Med (Lausanne). 2023 Aug 14;10:1125754. doi: 10.3389/fmed.2023.1125754. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37644986 Free PMC article.

3

[Severe cutaneous drug reactions in children].

Mockenhaupt M. Mockenhaupt M. Monatsschr Kinderheilkd. 2023;171(5):439-451. doi: 10.1007/s00112-023-01753-3. Epub 2023 Apr 18. Monatsschr Kinderheilkd. 2023. PMID: 37143471 Free PMC article. Review. German.

4

Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.

Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J, Schöpf E. Rzany B, et al. Among authors: mockenhaupt m. Br J Dermatol. 1996 Jul;135(1):6-11. Br J Dermatol. 1996. PMID: 8776350

5

Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC; EuroSCAR Study Group. Fagot JP, et al. Among authors: mockenhaupt m. AIDS. 2001 Sep 28;15(14):1843-8. doi: 10.1097/00002030-200109280-00014. AIDS. 2001. PMID: 11579247

6

Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC; SCAR Study Group. Severe Cutaneous Adverse Reactions. Auquier-Dunant A, et al. Among authors: mockenhaupt m. Arch Dermatol. 2002 Aug;138(8):1019-24. doi: 10.1001/archderm.138.8.1019. Arch Dermatol. 2002. PMID: 12164739

7

Interventions for toxic epidermal necrolysis.

Majumdar S, Mockenhaupt M, Roujeau J, Townshend A. Majumdar S, et al. Among authors: mockenhaupt m. Cochrane Database Syst Rev. 2002;2002(4):CD001435. doi: 10.1002/14651858.CD001435. Cochrane Database Syst Rev. 2002. PMID: 12519556 Free PMC article. Review.

8

EMPACT syndrome.

Mockenhaupt M, Roujeau JC. Mockenhaupt M, et al. J Dtsch Dermatol Ges. 2005 Jul;3(7):569-70; author reply 570. doi: 10.1111/j.1610-0387.2005.05039.x. J Dtsch Dermatol Ges. 2005. PMID: 15967019 No abstract available.

9

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Kardaun SH, et al. Among authors: mockenhaupt m. Br J Dermatol. 2007 Mar;156(3):609-11. doi: 10.1111/j.1365-2133.2006.07704.x. Br J Dermatol. 2007. PMID: 17300272 No abstract available.

10

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A. Mockenhaupt M, et al. J Invest Dermatol. 2008 Jan;128(1):35-44. doi: 10.1038/sj.jid.5701033. Epub 2007 Sep 6. J Invest Dermatol. 2008. PMID: 17805350 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters